FDA Adds Several Peptides to Category 2 Bulks List, Restricting Them From Compounding Restore Health Consulting The FDA just changed the rules on peptides effective April 15, 2026. BPC 157, GHK Cu, MOTS C, and TB 500 have been removed from the Category 2 restricted compounding list. Here is what FDA Peptide Update: Category 2 Removals Explained BPC 157 FDA Approval Status 2026: RFK Jr, Advisory Committee & Reclassification FDA Peptide Reclassification 2026: What It Means for Providers